Forum Financial Management LP Acquires 2,340 Shares of Danaher Corporation $DHR

Forum Financial Management LP raised its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 29.8% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 10,200 shares of the conglomerate's stock after buying an additional 2,340 shares during the quarter. Forum Financial Management LP's holdings in Danaher were worth $2,015,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the business. Ethic Inc. boosted its position in shares of Danaher by 7.5% during the second quarter. Ethic Inc. now owns 65,613 shares of the conglomerate's stock valued at $13,044,000 after purchasing an additional 4,552 shares in the last quarter. Parcion Private Wealth LLC purchased a new position in Danaher during the second quarter valued at $236,000. Exencial Wealth Advisors LLC raised its stake in Danaher by 56.1% during the second quarter. Exencial Wealth Advisors LLC now owns 18,595 shares of the conglomerate's stock valued at $3,673,000 after buying an additional 6,681 shares during the last quarter. FNY Investment Advisers LLC purchased a new position in Danaher during the second quarter valued at $435,000. Finally, Terra Alpha Investments LLC grew its holdings in Danaher by 9.9% during the second quarter. Terra Alpha Investments LLC now owns 15,759 shares of the conglomerate's stock valued at $3,113,000 after purchasing an additional 1,421 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Danaher Stock Performance

NYSE DHR opened at $218.06 on Thursday. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The firm has a market cap of $156.14 billion, a price-to-earnings ratio of 44.96, a price-to-earnings-growth ratio of 3.20 and a beta of 0.77. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $260.88. The business has a 50-day moving average price of $202.24 and a 200-day moving average price of $197.73.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.72 by $0.17. Danaher had a return on equity of 10.93% and a net margin of 14.44%.The business had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. During the same period in the prior year, the business posted $1.71 earnings per share. The company's quarterly revenue was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities research analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a dividend of $0.32 per share. The ex-dividend date is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher's dividend payout ratio is 27.23%.

Insider Transactions at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the company's stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. 11.10% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

DHR has been the subject of several recent research reports. Scotiabank raised Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price target for the company in a report on Friday, July 11th. Cowen reissued a "buy" rating on shares of Danaher in a report on Wednesday. Wells Fargo & Company boosted their price target on Danaher from $205.00 to $230.00 and gave the company an "equal weight" rating in a report on Wednesday. Weiss Ratings reissued a "hold (c-)" rating on shares of Danaher in a report on Wednesday, October 8th. Finally, Robert W. Baird set a $247.00 price target on Danaher in a report on Wednesday. Seventeen analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. According to data from MarketBeat.com, Danaher currently has an average rating of "Moderate Buy" and a consensus price target of $243.39.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.